Literature DB >> 6193234

Analysis of the mechanism of unresponsiveness produced by haptens painted on skin exposed to low dose ultraviolet radiation.

C A Elmets, P R Bergstresser, R E Tigelaar, P J Wood, J W Streilein.   

Abstract

Acute, low dose ultraviolet B radiation of murine body wall skin followed by local application of DNFB produces a state of antigen-specific unresponsiveness. This state is maintained at least in part by an Lyt-1+ T cell that effects unresponsiveness by impairing the induction phase of contact hypersensitivity. The absence of suppressor cells capable of acting at the effector stage of immunity suggests that tolerogenic signals derived from the skin establish suppressor networks that are incomplete and perhaps different from networks that are induced by systemic administration of tolerogens. It is proposed that ultraviolet radiation produces its effects by impairing the antigen-presenting potential of resident Langerhans cells in whose absence hapten-derivatized keratinocytes (or their products) are able to deliver a tolerogenic signal.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6193234      PMCID: PMC2187099          DOI: 10.1084/jem.158.3.781

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  30 in total

1.  Tolerance and contact sensitivity to DNFB in mice. VI. Inhibition of afferent sensitivity by suppressor T cells in adoptive tolerance.

Authors:  J W Moorhead
Journal:  J Immunol       Date:  1976-09       Impact factor: 5.422

2.  Epidermal Langerhans cells bear Fc and C3 receptors.

Authors:  G Stingl; E C Wolff-Schreiner; W J Pichler; F Gschnait; W Knapp; K Wolff
Journal:  Nature       Date:  1977-07-21       Impact factor: 49.962

3.  The induction of hapten-specific T cell tolerance using hapten-modified lymphoid membranes. II. Relative roles of suppressor T cells and clone inhibition in the tolerant state.

Authors:  S D Miller; M S Sy; H N Claman
Journal:  Eur J Immunol       Date:  1977-03       Impact factor: 5.532

4.  B-cell suppression of delayed hypersensitivity reactions.

Authors:  S I Katz; D Parker; J L Turk
Journal:  Nature       Date:  1974-10-11       Impact factor: 49.962

5.  Tolerance and contact sensitivity to DNFB in mice. 3. Transfer of tolerance with "suppressor T cells".

Authors:  P Phanupak; J W Moorhead; H N Claman
Journal:  J Immunol       Date:  1974-10       Impact factor: 5.422

6.  Depression of the T cell phenomenon of contact sensitivity by T cells from unresponsive mice.

Authors:  M Zembala; G L Asherson
Journal:  Nature       Date:  1973-07-27       Impact factor: 49.962

7.  Antigenicity of murine skin tumors induced by ultraviolet light.

Authors:  M L Kripke
Journal:  J Natl Cancer Inst       Date:  1974-11       Impact factor: 13.506

8.  Tolerance and contact sensitivity to DNFB in mice. I. In vivo detection by ear swelling and correlation with in vitro cell stimulation.

Authors:  P Phanuphak; J W Moorhead; H N Claman
Journal:  J Immunol       Date:  1974-01       Impact factor: 5.422

9.  Systemic alteration induced in mice by ultraviolet light irradiation and its relationship to ultraviolet carcinogenesis.

Authors:  M S Fisher; M L Kripke
Journal:  Proc Natl Acad Sci U S A       Date:  1977-04       Impact factor: 11.205

10.  Suppression of contact sensitivity by T cells in the mouse. I. Demonstration that suppressor cells act on the effector stage of contact sensitivity; and their induction following in vitro exposure to antigen.

Authors:  G L Asherson; M Zembala
Journal:  Proc R Soc Lond B Biol Sci       Date:  1974-11-05
View more
  64 in total

1.  A role for NF-kappaB-dependent gene transactivation in sunburn.

Authors:  K Abeyama; W Eng; J V Jester; A A Vink; D Edelbaum; C J Cockerell; P R Bergstresser; A Takashima
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

2.  Studies of delayed systemic effects of ultraviolet B radiation (UVR) on the induction of contact hypersensitivity, 2. Evidence that interleukin-10 from UVR-treated epidermis is the critical mediator.

Authors:  I Kurimoto; T Kitazawa; J W Streilein
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

Review 3.  Langerhans cells are initiators of the immunosuppressive effect of ultraviolet B radiation.

Authors:  P D Cruz
Journal:  Springer Semin Immunopathol       Date:  1992

Review 4.  The contribution of Langerhans cells to cutaneous malignancy.

Authors:  Julia Lewis; Renata Filler; Debra A Smith; Kseniya Golubets; Michael Girardi
Journal:  Trends Immunol       Date:  2010-11-09       Impact factor: 16.687

Review 5.  DNA damage, apoptosis and langerhans cells--Activators of UV-induced immune tolerance.

Authors:  Laura Timares; Santosh K Katiyar; Craig A Elmets
Journal:  Photochem Photobiol       Date:  2008-01-29       Impact factor: 3.421

Review 6.  Photoimmunology of experimental melanoma.

Authors:  C K Donawho; M L Kripke
Journal:  Cancer Metastasis Rev       Date:  1991-06       Impact factor: 9.264

7.  The effect of 1,25(OH)2-vitamin D3 on Langerhans cells and contact hypersensitivity in mice.

Authors:  Z Guo; H Okamoto; S Imamura
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

8.  Cell membrane is a major locus for ultraviolet B-induced alterations in accessory cells.

Authors:  J Krutmann; I U Khan; R S Wallis; F Zhang; E A Rich; J J Ellner; C A Elmets
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

9.  Imiquimod-induced TLR7 signaling enhances repair of DNA damage induced by ultraviolet light in bone marrow-derived cells.

Authors:  Rita Fishelevich; Yuming Zhao; Papapit Tuchinda; Hannah Liu; Ayako Nakazono; Antonella Tammaro; Tzu-Ching Meng; Jim Lee; Anthony A Gaspari
Journal:  J Immunol       Date:  2011-07-15       Impact factor: 5.422

10.  Bioactive grape proanthocyanidins enhance immune reactivity in UV-irradiated skin through functional activation of dendritic cells in mice.

Authors:  Mudit Vaid; Tripti Singh; Ram Prasad; Craig A Elmets; Hui Xu; Santosh K Katiyar
Journal:  Cancer Prev Res (Phila)       Date:  2013-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.